Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV Medicine

Volumn 16, Issue S1, 2015, Pages 109-118

  Baker, Jv ^a   Engen, Nw ^a   Huppler Hullsiek, K ^a   Stephan, C ^b   Jain, Mk ^c   Munderi, P ^d   Pett, S ^e   Duprez, D ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^d UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Arterial elasticity; Cardiovascular disease; HIV infection; Vascular dysfunction

Indexed keywords

ADULT; ARTERIAL ELASTICITY; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ELASTICITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; REPRODUCIBILITY; SELF REPORT; ARTERY; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANTIRETROVIRUS AGENT;

ADULT; ANTI-RETROVIRAL AGENTS; ARTERIES; CD4 LYMPHOCYTE COUNT; ELASTICITY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84923323561     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12239     Document Type: Article

References (41)

1. Freiberg MS, Chang CC, Kuller LH etal. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173: 614-622.
2. Seaberg EC, Munoz A, Lu M etal. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960.
3. Solages A, Vita JA, Thornton DJ etal. Endothelial function in HIV-infected persons. Clin Infect Dis 2006; 42: 1325-1332.
4. El-Sadr WM, Lundgren JD, Neaton JD etal. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296.
5. Friis-Moller N, Reiss P, Sabin CA etal. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723-1735.
6. Saves M, Chene G, Ducimetiere P etal. Risk Factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 2003; 37: 292-298.
7. Duprez DA, Neuhaus J, Kuller LH etal. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS ONE 2012; 7: e44454.
8. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009; 51: 268-273.
9. Baker JV, Huppler Hullsiek K, Singh A etal. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS 2014; 28: 831-840.
10. Chobanian AV, Bakris GL, Black HR etal. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
11. Cohn JN, Duprez DA. Time to foster a rational approach to preventing cardiovascular morbid events. J Am Coll Cardiol 2008; 52: 327-329.
12. Raggi P, Cooil B, Shaw LJ etal. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 2003; 92: 827-829.
13. Budoff MJ, Hokanson JE, Nasir K etal. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 2010; 3: 1229-1236.
14. Cao JJ, Arnold AM, Manolio TA etal. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007; 116: 32-38.
15. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep 2007; 9: 139-144.
16. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-1327.
17. Duprez DA, Jacobs DR, Jr, Lutsey PL etal. Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2011; 174: 528-536.
18. Ben-Shlomo Y, Spears M, Boustred C etal. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17, 635 subjects. J Am Coll Cardiol 2014; 63: 636-646.
19. Cohn JN, Duprez DA, Finkelstein SM. Comprehensive noninvasive arterial vascular evaluation. Future Cardiol 2009; 5: 573-579.
20. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
21. Charakida M, Masi S, Luscher TF, Kastelein JJ, Deanfield JE. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J 2010; 31: 2854-2861.
22. Stoner L, Sabatier MJ. Use of ultrasound for non-invasive assessment of flow-mediated dilation. J Atheroscler Thromb 2012; 19: 407-421.
23. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens 2003; 21: 463-472.
24. Tillin T, Chambers J, Malik I etal. Measurement of pulse wave velocity: site matters. J Hypertens 2007; 25: 383-389.
25. Finkelstein SM, Cohn JN. First- and third-order models for determining arterial compliance. J Hypertens Suppl 1992; 10: S11-S14.
26. Cohn JN, Finkelstein S, McVeigh G etal. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26: 503-508.
27. Valappil NI, Jacobs DR, Duprez DA, Gross MD, Arnett DK, Glasser SP. Association between endothelial biomarkers and arterial elasticity in yound adults: the CARDIA Study. J Am Soc Hypertens 2008; 2: 70-79.
28. Duprez D, Jacobs DR, Jr, Lutsey PL etal. Race/ethnic and sex differences in large and small artery elasticity: results of the multi-ethnic study of atherosclerosis (MESA). Ethn Dis 2009; 19: 243-250.
29. Peralta CA, Adeney KL, Shlipak MG etal. Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2010; 171: 63-71.
30. Peralta CA, Jacobs DR, Jr, Katz R etal. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60mL/min/1.73m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2012; 59: 41-49.
31. Baker JV, Duprez D, Rapkin J etal. Untreated HIV infection and large and small artery elasticity. J Acquir Immune Defic Syndr 2009; 52: 25-31.
32. Zimlichman R, Shargorodsky M, Boaz M etal. Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: reliability, repeatability, and establishment of normal values for healthy European population - the seven European sites study (SESS). Am J Hypertens 2005; 18: 65-71.
33. Babiker AG, Emery S, Fatkenheuer G etal. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials 2013; 10 (Suppl 1): S5-S36.
34. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121 (1 Pt 2): 293-298.
35. Goff DC, Jr, Lloyd-Jones DM, Bennett G etal. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (25 Suppl 2): S49-S73.
36. Duprez DA, Jacobs DR, Jr, Lutsey PL etal. Race/ethnic and sex differences in large and small artery elasticity-results of the multi-ethnic study of atherosclerosis (MESA). Ethn Dis 2009; 19: 243-250.
37. Sevastianova K, Sutinen J, Westerbacka J, Ristola M, Yki-Jarvinen H. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir Ther 2005; 10: 925-935.
38. Ho JE, Deeks SG, Hecht FM etal. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. AIDS 2010; 24: 1897-1905.
39. Eira M, Bensenor IM, Dorea EL, Cunha RS, Mill JG, Lotufo PA. Potent antiretroviral therapy for human immunodeficiency virus infection increases aortic stiffness. Arq Bras Cardiol 2012; 99: 1100-1107.
40. Ngatchou W, Lemogoum D, Ndobo P etal. Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients. Blood Press Monit 2013; 18: 247-251.
41. INSIGHT START Study Group. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Med 2015; 16 (Suppl 1): 1-9.